Repurposing FDA-approved anti-diabetic drug to target H. pylori peptidyl deformylase using computer-based drug discovery approach

AK Singh, S Maurya, S Kumar - Molecular Simulation, 2023 - Taylor & Francis
Peptide deformylase (PDF), a metalloenzyme is an important and attractive target in
antibacterial drug discovery. It removes the N-formyl group from the nascent peptide and …

In silico identification of potential γ-secretase inhibitor of marine-algal origin: an anticancer intervention

AK Singh, P Choudhary, S Singh, S Kumar - Molecular Simulation, 2023 - Taylor & Francis
Gamma secretase (GS) activates notch signalling pathway (NSP) by liberating the truncated
notch intracellular domain (NICD). The NSP is associated with the cancer development and …

[PDF][PDF] Identification of novel indole derivatives as potent α-amylase inhibitors for the treatment of type-II diabetes using in-silico approaches

K El Khatabi, R El-Mernissi, H Hajji, AK Singh, M Aziz… - 2022 - biointerfaceresearch.com
The α-amylase is regarded as a promising drug target for diabetes mellitus-type II. Hence,
inhibiting α-amylase activity is a potential drug discovery approach for treating this chronic …

Targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with synthetic/designer unnatural nucleoside analogs: an in silico study

SS Bag, S Sinha, S Dutta, HJ Baishya… - Journal of Molecular …, 2023 - Springer
Context Since the outbreak of COVID-19 in December 2019, it developed into a pandemic
affecting all the countries and millions of people around the globe. Until now, there is no …

Exploring the mangrove based phytochemicals as potential viral RNA helicase inhibitors by in silico docking and molecular dynamics simulation method

R Satpathy, S Acharya - Математическая биология и …, 2023 - mathnet.ru
The high molecular diversity of plant-derived compounds in mangroves has drawn attention
to the discovery of their antiviral capacity against several pathogenic viruses. Therefore …

Two-component EvgS protein subdues both antimicrobial resistance and virulence in Shigella flexneri 2a str. 301

A Naha, S Ramaiah - Authorea Preprints, 2024 - authorea.com
Shigella flexneri 2a is one of the leading bacterial agents of diarrhoeal mortality in humans.
Recently, multi-drug resistance strains have posed severe challenges. The present study …

[HTML][HTML] A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2

U Chaube, BD Patel, HG Bhatt - 3 Biotech, 2023 - Springer
Vaccines are used as one of the major weapons for the eradication of pandemic. However,
the rise of different variants of the SARS-CoV-2 virus is creating doubts regarding the end of …

Clinical and molecular analysis of a novel variant responsive to salbutamol monotherapy during COVID-19 outbreak related to congenital and late-onset of …

Z Nouri, J Saffari-Chaleshtori, A Sarmadi, M Sehhati… - 2024 - researchsquare.com
Background: Congenital myasthenic syndromes (CMSs) are a group of clinically and
genetically heterogeneous disorders. Mutations in the DOK7 gene underlie CMS with …

Designing of neoepitopes based vaccine against breast cancer using integrated immuno and bioinformatics approach

M Shuaib, AK Singh, S Gupta, AF Alasmari… - Journal of …, 2023 - Taylor & Francis
Cancer is characterized by genetic instability due to accumulation of somatic mutations in
the genes which generate neoepitopes (mutated epitopes) for targeting by Cytotoxic T …

[PDF][PDF] Discovery of natural anti-apoptotic protein inhibitor using molecular docking and MM-GBSA Approach: An anticancer intervention

S Dey, AK Singh, S Kumar - 2022 - biointerfaceresearch.com
Apoptosis is a programmed molecular phenomenon in normal cells, and" evading
apoptosis" is a hallmark of cancer. Overexpression of anti-apoptotic BCL-2 promotes cancer …